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Calorie-restrictionCholecystokinin (CCK) is anorexic, irrespective whether it is applied intraperitoneally (IP) or
intracerebroventricularly (ICV) inmaleWistar rats. Themetabolic effects depend on the route of administration:
by the IP route it elicits hypothermia (presumably by type-1 receptors, CCK1R-s), while ICV administration is
followed by fever-like hypermetabolism and hyperthermia via activation of CCK2R-s, which latter response
seems to bemost important in the postprandial (compensatory) hypermetabolism. The efﬁcacy of the IP injected
CCK varies with age: it causes strong anorexia in young adult 4 and 6-months old and again in old rats (aged 18–
24 months), but the middle-aged (12-month old) ones seem to be resistant to this effect. Such pattern of effects
may contribute to the explanation of age-related obesity observed inmiddle-aged animals aswell as to the aging
anorexia and loss of body weight in old ones. Diet-induced obesity accelerates the appearance of CCK-resistance
as well as the return of high sensitivity to CCK in further aging, while chronic calorie-restriction prevents the devel-
opment of resistance, as if the speed of the age-related regulatory changes was altered by the nutritional state.
The effects of ICV applied CCK also change with age: the characteristic anorexic and hypermetabolic/hyperthermic
effects can be observed in young adult rats, but the effects gradually and monotonically decline with age and
disappear by the old age of 24 months. These disparate age-related patterns of CCK efﬁcacy upon peripheral or
central administration routes may indicate that although both peripheral and central CCKR-s exert anorexic effects,
they may have dissimilar roles in the regulation of overall energy balance.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
A number of peptide hormones have been shown to inﬂuence the
components of energy balance (food intake, metabolic rate, body
weight, body temperature, etc.) by having either an overall anabolic or
catabolic effect (Szekely et al., 2010). The roles played by these peptides
are not standard in the course of life: in the regulation of energy balance
both the role(s) of individual peptides and their interactions change
continuously.
Inmammals, including humans, aging is accompanied by characteris-
tic alterations in energy balance (Pétervári et al., 2011). At a juvenile age
the balance is positive (calorie intake exceeds energy expenditure) in
order to serve the growth and development of the body. In young adults
the anabolic (orexigenic and hypometabolic) and catabolic (anorexigen-
ic and hypermetabolic) mechanisms are balanced. However, later on inhysiology and Gerontology,
eti str., Hungary. Tel.: +36 72
).
.Open access under CC BY-NC-ND licenmiddle-aged subjects the common age-related obesity (Scarpace et al.,
2000) suggests a shift towards anabolic processes, while at old age the
characteristic aging anorexia (Chapman et al., 2002), that is often accom-
panied by senile sarcopenia, indicates excess of catabolic mechanisms.
Both obesity and sarcopenia have serious medical consequences
even if not related to age. The peptidergic regulation of energy balance
and the effects of neuropeptides may vary not only with age but also
with pre-existing body composition (obesity, undernutrition).
Cholecystokinin (CCK) has been recognized for over a century as one
of the ﬁrst known hormones, with a function to enhance gallbladder's
motility. By now, it is clear that this gastrointestinal peptide has several
other functions in forwarding and digesting the consumed food, and
also that it causes satiety (Moran et al., 2006). The latter effect indicates
that CCK as a peptide hormone of the brain–gut axis can inﬂuence
cerebral functions related to energy balance. Controversial data have
been reported concerning the contribution of CCK to the maintenance
of energy balance. Lo and coworkers demonstrated that CCK knock-
out mice proved to be resistant to high-fat diet-induced obesity (Lo
et al., 2010). However, this mouse strain also showed impaired fat
absorption and enhanced metabolic rate that some authors attribute
to their genetic background (Lacourse et al., 1999). Lack of CCK
may also have contributed to the fat malabsorption due to impaired
gallbladder function. Although such studies do not contradict these.
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they demonstrate the complexity of CCK effects.
Food intake enhances CCK production not only in the upper gastro-
intestinal tract but also in the hypothalamus (Schick et al., 1990, 1994),
with obvious central effects in this latter case. Although peripheral CCK
has certain central actions, the central functions of CCK of peripheral
or central origin may not be identical.
Peripheral type-1 CCK receptors (CCK1R-s) are located mainly on
the afferent ﬁbers of the abdominal vagus (Smith et al., 1985; South
and Ritter, 1988), although some CCK1R-s have been detected also in
the brain (Hirosue et al., 1993). The nucleus of the solitary tract (NTS)
serves as a portal for assessing and integrating visceral afferent signals
(including CCK-related signals), while the dorsalmotor nucleus provides
outbound signals towards neurons of the rostral medullary raphe to in-
ﬂuence efferent responses (Berthoud, 2004; Blessing, 1997). This system
seems to function on the basis of awithin-meal negative feedback satiety
signal and it is important mainly in determining the short-term regula-
tion of food intake (Balaskó et al., 2012; Moran et al., 2006; West et al.,
1984) according to the actual feeding state. The role of this system
in the long-term regulation of nutritional state (adiposity) is less clear.
Peripherally applied CCK in pharmacological doses elicited hypothermia
(Kapás et al., 1987) presumably by a vagal reﬂex effect causing hypo-
metabolism, skin vasodilation and consequently increased heat loss,
independent of the role of CCK in the regulation of food intake and
energy balance.
In contrast to peripheral administration, centrally applied CCK acts
mainly on CCK2R-s of hypothalamic and other nuclei (Mercer et al.,
2000). Centrally injected CCK is known to induce fever-like coordinated
changes in energy balance: an increase in metabolic rate, a decrease in
heat loss, an elevation of body temperature (Szelényi et al., 1994), and
it also evokes anorexia (Gibbs et al., 1973). In endotoxin fever CCK2R-
s are also involved (Székely et al., 1994).
The aim of the present study was to investigate whether or not,
and how, peripheral vs. central CCK-related effects may contribute to
changes of energy balance in the course of aging. A further aim was to
check whether nutritional state can inﬂuence the effects of CCK, since
the efﬁcacy of other peptides have been shown to vary not only with
age but also with nutritional state (Soos et al., 2011).
2. Materials and methods
2.1. Animals
Male Wistar rats from the colony of the Department of Pathophysi-
ology and Gerontology were used in the experiments. After weaning
the animals were kept individually in plastic cages (375 × 215 mm,
height 149 mm, covered by steel grid and equipped with feeder and
bottle container) with somewood-chip bedding at an ambient temper-
ature of 22–25 °C. The lights were on between 06.00 and 18.00 h.
Standard rat chow(CRLT/N rodent chow, SzindbádKft., Gödöllő, Hungary,
11 kJ/g) and tap water were continuously available (food but not water
was removed for a 48-h period in some groups). Among these normally
fed (NF) rats different age-groups have been established: 2, 4, 6, 12, 18
and 24 month old animals (NF2, NF4, NF6 and NF12, NF18 and NF24)
represented juvenile, young adult, younger and older middle-aged,
aging and old age-groups, respectively. (The maximal life-span of our
colony reaches 30 months, about 50% of rats survive 26 months, but
after the age of 24 months surgical interventions are difﬁcult.)
Some animals were calorie-restricted (CR) from age 2 months
onwards: they received 2/3 of the normal daily amount of standard
chow (16 g/day), with vitamin and mineral supplementation and un-
limited water intake. Some other 6 and 12-month-old rats were made
obese by using a high-fat diet (HF, using diet-induced obesity rodent
puriﬁed diet with 60% Energy from Fat, IPS TestDiet®, 21.6 kJ/g) from
age 2 months. For 10–14 days before and also during the experimental
procedures rats that participated in the assessment of CCK effects onfood intake received a powdered form of their respective types of
chow and were transferred to an automated FeedScale system which
allowed continuous recording of their food consumption and prevented
food hoarding. The powdered version of the high-fat diet contained
10% normal powdered chow admixed to the powdered high-fat pellets
(20.54 kJ/g). Bodyweight and spontaneous daily food intakeweremea-
sured every day at 09.00 h— thereby the animals were also accustomed
to regular handling. Rats used in the analysis of metabolic rate and body
temperature were habituated for at least a week prior to experiments
to semi-restraining boxes in which they were able to move somewhat
forward and backward but not to change the head-to-tail position.
All experiments and interventions were undertaken according to
the general rules and special approval of the University of Pécs Ethical
Committee for the Protection of Animals in Research (BA 02/2000-11/
2011), in accordance with the directives of the National Ethical Council
for Animal Research and those of the European Communities Council
(86/609/EEC).
2.2. Surgical interventions
For intracerebroventricular (ICV) injections a 22-gaugemetal leading
cannula was stereotaxically implanted into the right lateral cerebral
ventricle (parameters: 1 mm posterior and 1.5 mm right lateral to
bregma, 3.5 mm ventral to dura) for chronic use, under intraperitoneal
(IP) ketamine + xylazine [78 mg/kg (Calypsol, Richter) + 13 mg/kg
(Sedaxylan, Eurovet)] anesthesia. The cannula was ﬁxed to the skull by
dental cement with the help of 2 miniature screws into the bone.
The lumen of this cannula was regularly closed by a stylet— at injections
the stylet was replaced by a ﬁtting 28-gauge injection cannula that
was connected to a pp10 polythene tube for remote ICV injections. For
in vivo testing of the cannula's placement angiotensin II (20 ng/5 μl)
was injected and the subsequent water consumption was measured:
the test was positive and the location of the cannula was assumed
to be optimal if at least 5 ml water was consumed within 30 min
(Pétervári et al., 2010).
Following the experiments the animals were euthanized by an IP
injection of urethane and the injection sites of their brainswere checked
macroscopically by coronal sections of the removed and ﬁxed brains.
(Data of rats with inappropriately placed cannula were excluded from
the statistical analysis.) Simultaneously, the left retroperitoneal and
epididymal fat pads were removed and weighed, along with the tibialis
anterior muscle, as indicators of body composition (Soos et al., 2010).
All body composition indicators were calculated for 100 g body weight.
2.3. Administration of substances
Cholecystokinin-8 (Bachem) or solvent pyrogen-free saline (PFS)
was administered either by direct IP injections at a dose of 5 μg
(4.4 nmol) in a volume of 0.5 ml for assessment of anorexigenic effects
(see Section 2.4), in other cases at a pharmacological dose of 100 μg
(88 nmol, as applied in earlier studies, Kapás et al., 1987) in a volume
of 0.1 ml in metabolic studies (see Section 2.5), or by ICV injections at
a dose of 500 ng (0.44 nmol) in a volume of 5 μl for both anorexigenic
and metabolic tests. In the analysis of anorexia the injections were
given 5 min prior to presentation of food, while in the metabolic studies
CCK was injected after the animals reached a thermal steady state
(usually 60–90 min after closing the metabolic chamber). For mea-
surements of metabolic rate and body temperature, the ways of CCK
administration were slightly different (see Section 2.5).
2.4. Assessment of CCK effects on food intake in function of age and
nutritional state
The anorexigenic responsiveness to IP or ICV CCK injections was
assessed in a number of rats (6–8 rats per group) from different popu-
lations according to age and nutritional state via measuring their
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induced by 48-h food deprivation (from 09.00 on day 1 until 09.00
on day 3). In control experiments PFS was used. The consumed food
was measured in a Feed-Scale system (Columbus), which allowed ﬁne
assessment of the rate of feeding. The data were collected in 30-min
periods. Normally fed animals at ages 2, 4, 6, 12, 18 and 24 months, a
group of CR animals (CR12 with unlimited access to powdered chow
during the 3-h re-feeding), and two groups of HF rats (HF6 and HF12)
were tested in the experiments.Table 1
Body weight values (BW) before a 48-h fasting and cumulative energy intake (FI) during
the consequent 3-h re-feeding of rats belonging to different age-groups and nutritional
states.
Group (age and nutritional state) BW (g) before fasting 3 h cumulative FI (kJ)
NF2 control 208.9 ± 5.6 78.4 ± 6.8
NF2 CCK 209.6 ± 1.6 72.3 ± 6.2
NF4 control 396.2 ± 12.2 134.1 ± 5.8
NF4 CCK 395.7 ± 11.4 99.0 ± 6.9c
NF6 control 467.5 ± 14.6 137.5 ± 17.2
NF6 CCK 466.8 ± 12.6 89.7 ± 7.6c
HF6 control 565.0 ± 13.9⁎ 215.6 ± 24.3a
HF6 CCK 546.6 ± 15.5⁎ 181.9 ± 31.1
NF12 control 534.7 ± 10.4 86.9 ± 3.2
NF12 CCK 529.1 ± 12.9 78.1 ± 5.6
HF12 control 710.1 ± 24.6# 153.4 ± 13.9b
HF12 CCK 682.3 ± 23.5# 98.7 ± 13.5c
CR12 control 324.4 ± 5.5⁎ 139.7 ± 11.7b
CR12 CCK 327.4 ± 5.7⁎ 73.9 ± 9.8c
NF18 control 536.3 ± 17.2 102.7 ± 10.7
NF18 CCK 518.8 ± 7.2 71.5 ± 5.8c
NF24 control 514.9 ± 17.5 102.7 ± 7.7
NF24 CCK 511.8 ± 30.2 64.9 ± 6.6c
Values are expressed as the mean ± S.E.M. for six-eight rats in each group.2.5. Assessment of CCK effects on metabolic rate and body temperature
Normally fed rats from groups of various ages were singly enclosed
in restraining cylindrical boxes of corresponding size and placed into a
tightly sealed plexiglass metabolic chamber (size: 20 × 30 × 18.5 cm)
that was perfused by a standard gas mixture (corresponding to “stan-
dardized” roomair). The chamberwas immersed into a thermostatically
controlledwater-bath to secure standard (25 °C or 28 °C, i.e., lower end of
the thermoneutral zone or within thermoneutrality) or cool (20 °C) am-
bient temperature (Ta) for the experimental animals. Copper-constantan
thermocouples were attached to the rats for measuring colonic (core)
and tail skin temperatures (Tc and Ts, respectively): these – together
with the thermocouple for the chamber – were exteriorized from
the sealed chamber.
An injection cannula inserted into the chronically preimplanted ICV
cannula was connected to a 20–25-cm-long pp10 polythene (Portex)
tube (Szelényi et al., 1994). The tube contained at the cranial end the
peptide in a volume of 5 μl separated by a small bubble from the PFS
ﬁlling the rest of the tube, which was closed and exteriorized together
with the thermocouples. At injections, 5 μl PFS was slowly injected
at the outer end of the tube, thereby the CCK was injected ICV without
disturbing the animal.
For IP injections the cannula was acutely inserted (through the
lumen of a needle) prior to the experiment to the abdominal cavity,
ﬁxed by sticky tape and the animal was placed into the restraining box.
Both the cannula and the thermocouples were exteriorized similarly as
described previously.
Oxygen consumption, CO2 production and respiratory quotient (RQ)
were determined by the help of an Oxymax gas analyzer (Columbus,
OH) and the data were electronically processed.
All temperature data were collected by a Digi-Sense 12-channel
scanning Benchtop thermometer (Cole-Parmer) for electronic evalua-
tion. Heat loss state (“heat loss index”, HLI, as used in earlier studies;
Romanovsky et al., 2000) was assessed from the relationship of
the three monitored temperatures [HLI = (Ts − Ta) / (Tc − Ta)]: Ts
values approaching Ta (HLI near 0) suggested vasoconstriction as a
sign of heat conservation state, while those Ts values nearer to Tc (HLI
near 1) suggested vasodilation as an early manifestation of general
enhancement of heat loss activity.
This methodology of indirect calorimetry allowed assessment
of metabolic rate (O2 consumption) and that of RQ, while from
the relationship of the measured temperatures HLI was calculated.
These data reﬂect heat production and heat loss states, respectively,
together with the consequent core temperature.NF: normally fed, HF: high-fat diet-induced obese, CR: calorie-restricted.
Numbers following the above abbreviations of animal groups indicate the age of the rats in
months.
BW values of control vs. CCK-treated groups of the same age and nutritional state did not
differ. Concerning initial BW values the following statistically signiﬁcant differences were
denoted in the table: # HF12 vs. all other groups (p b 0.001), ⁎ HF6 or CR12 vs. age-
matched NF (HF6 vs. NF6 p b 0.01, CR12 vs. NF12 p b 0.001).
Regarding 3-h cumulative FI values of control groups the following statistically signiﬁcant
differences were denoted in the table: “a” HF6 vs. all other groups (p b 0.05), “b” HF12
or CR12 vs. age-matched NF (HF12 vs. NF12 p b 0.001, CR12 vs. NF12 p b 0.01).
CCK treatment reduced 3-h cumulative FI signiﬁcantly compared to controls of the same
age and nutritional state in the following groups: “c” NF4 (p = 0.001), NF6 (p = 0.015),
NF18 (p = 0.015), NF24 (p = 0.006), HF12 (p = 0.015), CR12 (p = 0.001).2.6. Statistical analysis
Experimental results are presented as mean ± S.E.M. Groups of
different ages and body compositions contained at least 6–8 rats.
For statistical analysis of the data SPSS 11.0 for Windows software
was applied for one-way ANOVA with Scheffe's post hoc tests and
SigmaPlot for Windows version 11.0 was applied for regression
analysis. Differences reaching p b 0.05 were considered to be statis-
tically signiﬁcant.3. Results
Bodyweight (BW) (Table 1) and body composition values (calculated
for 100 g BW) of different NF age-groups (Fig. 1 and Table 2) were in
accord with those observed in our previous studies (Pétervári et al.,
2010): up to 12 months of age BW showed a rising tendency with a pla-
teau phase between 12 and 18 months, then it started to decline slowly.
In juvenile rats BW and fat mass indicators were signiﬁcantly smaller
than those of all other groups. No difference inmusclemasswas detected
in any group, except for the oldest (24 months old) sarcopenic animals.
Body weight (Table 1) and fat content of HF rats exceeded those
of age-matched NF controls, while the relative muscle mass remained
similar (Fig. 1 and Table 2). Body composition indicators of NF6 vs.
HF6 rats were as follows: epididymal fat: 0.35 ± 0.04 vs. 0.77 ±
0.07 g/100 g BW (p b 0.001); retroperitoneal fat: 0.39 ± 0.07 vs.
1.07 ± 0.15 g/100 g BW (p = 0.002). Similar ratios were observed in
the NF12 vs. HF12 groups: epididymal fat: 0.52 ± 0.04 vs. 1.00 ±
0.05 g/100 g BW (p b 0.001); retroperitoneal fat: 0.50 ± 0.03 vs.
1.82 ± 0.19 g/100 g BW (p b 0.001). Fat mass and BW values of HF12
were signiﬁcantly higher than those of all other rats. Although HF6
weighed less than HF12, their BW was comparable to (or even higher
than that of) NF12, twice their age (Table 1).
Body weight (Table 1) and fat content (Fig. 1) of CR12 rats were
signiﬁcantly smaller than those of age-matchedNF controls. These values
were similar to those of much younger NF4 animals. While fat mass was
signiﬁcantly reduced, no decline of muscle mass was observed com-
pared to NF12 (Fig. 1 and Table 2): epididymal fat: 0.52 ± 0.04 vs.
0.26 ± 0.03 g/100 g BW (p = 0.002); retroperitoneal fat: 0.50 ± 0.03
vs. 0.14 ± 0.03 g/100 g BW (p b 0.001) (NF12 vs. CR12, respectively).
Upon 48-h fasting weight loss of NF age-groups ranged from 7% to
10% of initial BW except for a 14% BW fall in the 2 month old juvenile
group. Weight loss of CR12 rats reached about 10%, while HF animals
lost merely 4–6%. In NF rats, the subsequent cumulative 3-h energy
Fig. 1. Indicators of fat mass in rats of different age-groups and nutritional states given for
100 g body weight (BW). Asterisks indicate signiﬁcant differences between values of rats
of the same age and different nutritional states. Detailed statistical analysis of the data
is described in the Results section. NF: normally fed, HF: high-fat diet-induced obese,
CR: calorie-restricted. Numbers following the abbreviations of animal groups indicate
the age of the rats in months.
Fig. 2. Reduction in the 48-h fasting-induced cumulative 3-h food intake (FI) expressed in
kJ/100 g body weight (BW, after fasting, before re-feeding) in different age-groups and
nutritional states of rats following intraperitoneal (IP) cholecystokinin (CCK) treatment.
Values (columns) are expressed as the mean ± S.E.M. for six-eight rats in each group.
The rate of reduction is denoted above the pairs of columns in percentage of the corre-
sponding control value. Asterisks indicate signiﬁcant differences between re-feeding
values of IP CCK-treated (dark columns) and control [pathogen-free saline (PFS)-treated]
rats of the same age and nutritional state (light columns): NF4 p = 0.003, NF6 p = 0.009,
NF18 p = 0.037, NF24 p = 0.004, HF12 p = 0.026, CR12 p = 0.001. NF: normally fed,
HF: high-fat diet-induced obese, CR: calorie-restricted, NS: non-signiﬁcant. NF: normally
fed, HF: high-fat diet-induced obese, CR: calorie-restricted. Numbers following the above
abbreviations of animal groups indicate the age of the rats in months.
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dependent decline from NF2 to NF12 and remained at the same level
thereafter (Fig. 2). Re-feeding expressed in kJ was the largest in the
HF animals, and values of HF6 exceeded those of HF12 (Table 1).
When calculated for 100 g BW, 3-h energy intake of HF6 was circa
twice as high as that of HF12 (40.7 ± 4.7 vs. 22.5 ± 2.0 kJ/100 g BW,
Fig. 2). Regarding CR12 rats, their cumulative 3-h energy intake in kJ-s
following 48-h fasting was also very high: it exceeded signiﬁcantly the
value of NF12, but did not differ from that of HF12 of a much higher
BW (Table 1). When expressed in kJ/100 g BW re-feeding energy intake
of CR12 was the largest of all rats (47.8 ± 4.2 kJ/100 g BW, Fig. 2).
3.1. CCK-effects on food intake
In young adult rats the IP administered CCK caused signiﬁcant
suppression of 3-h cumulative food intake during re-feeding after 48-
h fasting. In order to demonstrate the different rates of suppression
Fig. 2 shows these data in kJ/100 g BW. Compared to the suppression
seen in the young adult group, themost pronounced effectwas observed
at the age of 6 months. However, CCKwas ineffective in juvenile animals
and in middle-aged ones (NF12). Interestingly, at later ages (NF18,
NF24) the suppression of re-feeding energy intake became again
pronounced and statistically signiﬁcant. Regarding the anorexic
efﬁcacy of CCK in different age groups, the highest relative dose
normalized to BW (Supplement 1) failed to elicit signiﬁcant effects
in NF2, proceeding to exert reduction in food intake despite lowerTable 2
Indicator of muscle mass in rats of different age-groups and nutritional states.
Group (age and nutritional state) Tibialis anterior muscle (g/100 g body weight)
NF2 0.18 ± 0.01
NF4 0.17 ± 0.01
NF6 0.20 ± 0.01
HF6 0.19 ± 0.01
NF12 0.19 ± 0.01
HF12 0.18 ± 0.01
CR12 0.20 ± 0.01
NF18 0.17 ± 0.01
NF24 0.13 ± 0.01⁎
Asterisk indicates signiﬁcant decline in muscle mass indicator of NF24 vs. all other groups
(p b 0.001).
NF: normally fed, HF: high-fat diet-induced obese, CR: calorie-restricted.
Numbers following the above abbreviations of animal groups indicate the age of the rats
in months.relative CCK doses in NF4 and NF6. Although middle-aged rats
were characterized by a low relative dose with a lack of CCK-
anorexia, the same low relative dose proved to be efﬁcient from
NF18.
Alterations in body composition inﬂuenced this pattern of CCK
efﬁcacy. Obese HF6 rats (with low relative dose, see Supplement 1)
were resistant to the anorexic effect of CCK (Fig. 2) already at the age
of 6 months, but the anorexic effect became again signiﬁcant in HF12
animals (lowest relative dose). In contrast, during re-feeding CR12 rats
consumed much more food than age-matched controls (they appeared
to be hungrier than rats of the NF12 group), but CCK almost halved
the consumption (Fig. 2), unlike in NF12 animals.
The ICV injected CCK (Fig. 3) was also without signiﬁcant effect
on food intake in juvenile rats, but caused extreme anorexia in NF4
and NF6 animals (peak suppression in NF6). The effect was attenuated
but still signiﬁcant in the middle-aged NF12 group, and – in contrast to
the IP administration – it further decreased and became non-signiﬁcant
in the old NF24 animals. These results suggested an age-related mono-
tonous decrease in the anorexic effect of centrally applied CCK.
3.2. Effects of CCK on metabolic rate and thermoregulation
For thermoregulatory analysis of CCK, different ambient temper-
atures were applied: thermoneutrality (25–28 °C) allows the activa-
tion of vasodilation (heat loss), and a cool environment (20 °C) that
elicits an increase in metabolic rate, permits the appearance/study
of hypometabolic effects.
In line with the data of the literature (Kapás et al., 1987), young adult
NF4 rats respondedwith hypothermia to IP injection of a pharmacological
dose of CCK, due either to skin vasodilation (at a thermoneutral ambient
temperature, Fig. 4A) or to a decrease inmetabolic rate (at a cool ambient
temperature, Fig. 4B). For technical reasons, dependence of the hypo-
thermic response on age or nutritional state was not analyzed in the
present study.
In young adult NF4 rats the metabolic effects of ICV injected CCK
appeared to be coordinated (Fig. 4C). Centrally applied CCK caused
an immediate signiﬁcant rise in oxygen consumption with a decreasing
Fig. 3. Reduction in the 48-h fasting-induced cumulative 3-h food intake (FI) expressed
in kJ/100 g body weight (BW after fasting, before re-feeding) in different age-groups of
rats following intracerebroventricular (ICV) cholecystokinin (CCK) treatment. Values are
expressed as the mean ± S.E.M. for six-eight rats in each group. The rate of reduction
is denoted above the pairs of columns in percentage of the corresponding control value.
Asterisks indicate signiﬁcant differences between re-feeding of ICV CCK-treated (dark
columns) and control [pathogen-free saline (PFS)-treated] rats of the same age: NF4
p b 0.001, NF6 p b 0.001, NF12 p b 0.001. NF: normally fed, HF: high-fat diet-induced
obese, CR: calorie-restricted. Numbers following the above abbreviations of animal groups
indicate the age of the rats in months.
Fig. 4. Effects of intraperitoneal (IP) or intracerebroventricular (ICV) cholecystokinin (CCK) a
recordings of core temperature (Tc), heat loss index (HLI) and oxygen consumption (VO2) in
empty symbols represent controls [effects of pathogen-free saline (PFS) injection]. Panel A: CC
IP (100 μg) at an ambient temperature of 20 °C. Panel C: CCKwas applied ICV (500 ng) at an am
(Tc), heat loss index (HLI) and oxygen consumption (VO2) in normally fed 4 months old rats. Fu
[effects of pathogen-free saline (PFS) injection]. Panel A: CCKwas injected IP (100 μg) at an amb
of 20 °C. Panel C: CCK was applied ICV (500 ng) at an ambient temperature of 25 °C.
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what enhanced fat utilization) that did not reach statistical signiﬁcance
(p = 0.061, Fig. 5). At the lower end of the thermoneutral zone (25 °C)
CCK caused no change in tail vasomotor tone and Ts, i.e., the skin
vasoconstriction persisted. This response corresponds to the febrile
reaction seen in response to lipopolysaccharide or prostaglandin E,
and the anorexic effect ﬁts the pattern of sickness behavior adjoining
fever.
Similarly as the anorexic response, the metabolic response to ICV
CCK was age-dependent (Fig. 6). The hypermetabolic/hyperthermic
response that was characteristic for the NF4 rats became smaller,
though still signiﬁcant in NF6 and NF12 animals compared with the
PFS-treated controls, but with further aging the response became even
smaller and neither statistically nor biologically signiﬁcant in the NF18
and NF24 old age-groups. A negative linear correlation was shown be-
tween age and the CCK-induced change in Tc of individual rats (Fig. 7).
Correlation coefﬁcient of the linear regression was r = −0.648. Thus,
the hypermetabolic effect exhibited a monotonous decline with aging,
similarly as seen in the case of the age-related decline of the anorexic
effect of ICV CCK.
4. Discussion
In our study the high-fat diet induced signiﬁcant weight gain and
an accumulation of fat as shown by the body composition indicators.
Body weight and fat mass indicators of the obese 6-month old rats
exceeded those of normally fed oldermiddle-aged 12-month old animals
suggesting a premature onset of “middle-aged” obesity induced by administration on metabolic rate and thermoregulation. The curves represent individual
normally fed 4 month old rats. Full symbols represent changes following CCK-treatment,
K was injected IP (100 μg) at an ambient temperature of 28 °C. Panel B: CCK was injected
bient temperature of 25 °C. The curves represent individual recordings of core temperature
ll symbols represent changes following CCK-treatment, empty symbols represent controls
ient temperature of 28 °C. Panel B: CCKwas injected IP (100 μg) at an ambient temperature
Fig. 5. Effect of intracerebroventricular (ICV) cholecystokinin (CCK) administration on respiratory quotient (RQ). Panel A: The curve represents an individual recording of RQ upon CCK
injection in a normally fed 4 month old rat. Panel B: RQ values expressed asmean ± S.E.M. for a group of normally fed 4 month old rats before and after (at 120 min) an ICV CCK injection.
1185M. Balaskó et al. / Experimental Gerontology 48 (2013) 1180–1188high-fat diet. On the other hand, these parameters of calorie-restricted
representatives of the 12-month age-group were signiﬁcantly smaller
than those of their normally fed controls. Moreover, these parameters
were reduced below those of much younger normally fed 4-month old
animals. This suggests an efﬁcient prevention of “middle-aged” obesity
by the applied level of calorie-restriction.
Our results regarding the peripheral administration of CCK show
that aging did not cause a gradual continuous decline in the efﬁcacy
of the peptide, rather age-related phasic changes were demonstrated
for the anorexigenic CCK effect.
Whether given IP or ICV, in young adult NF4 and youngmiddle-aged
NF6 rats CCK signiﬁcantly suppressed food intake (although the ICV
applied 500 ng dose exerted stronger anorexigenic response in young
adult rats than the IP injected 5 μg). Interestingly, both types of
administration were ineffective in juvenile NF2 animals, suggesting
thepresence of an extremely strongorexigenic tone at this age. In juvenileFig. 6.Cholecystokinin (CCK)-inducedhyperthermia indifferent age-groups of rats. Values
are expressed as themean ± S.E.M. for six-ten rats in each group. Initial core temperature
valueswere similar in all groups (ranging from 37.4 ± 0.2 to 37.7 ± 0.2 °C). Full columns
represent changes in core temperature (ΔTc) at 120 min following an intracerebroven-
tricular (ICV) CCK injection (500 ng), empty columns indicate similar values of controls
following ICV pathogen-free saline (PFS) injections. Asterisks indicate signiﬁcant differ-
ences between ΔTc of ICV CCK-treated and control rats of the same age: NF2 p = 0.009
NF4 p b 0.001, NF6 p = 0.002, NF12 p b 0.001. NS: non-signiﬁcant. NF: normally fed,
HF: high-fat diet-induced obese, CR: calorie-restricted. Numbers following the above
abbreviations of animal groups indicate the age of the rats in months.rats a similar “resistance” was demonstrated for the anorexic effect
of alpha-melanocyte stimulating hormone (alpha-MSH) — this was
also explained by a high orexigenic tone, that is speciﬁc for this age of
fast growth (Pétervári et al., 2010).
The anorexic effect of IP CCK observed in young adult rats is in line
with the data of the literature (Balaskó et al., 2012; Smith and Gibbs,
1998). Signals representing information from stretch of the stomach
and from the nutrient composition of its content are conveyed by ﬁbers
of the abdominal afferent vagus (Berthoud, 2004; Blessing, 1997; South
and Ritter, 1988) to the NTS, brainstem, and further structures of the
brain. The hindbrain alone is sufﬁcient for the development of such
CCK-anorexia: peripheral CCK causes satiety even in decerebrate ani-
mals (Grill and Smith, 1988), but not in animals with NTS lesion
(Edwards et al., 1986). Someof the vagal afferentﬁbers (C-type) contain
CCK1R-s and they are capsaicin sensitive,while other (A-type)ﬁbers are
insensitive. In rats, systemic capsaicin desensitization prevented the
satiety induced by IP CCK (South and Ritter, 1988). However, decere-
brate animals can only adapt to the short-term feeding state but not
to long-term changes in nutrition (starvation, overfeeding). If CCK can
indeed inﬂuence the long-term changes of energy balance, or such
changes of nutritional state (starvation, obesity) can interfere with the
effects of peripheral CCK, then other additional point(s) of action mustFig. 7.Dependence of core temperature changes (ΔTc) induced by intracerebroventricular
cholecystokinin (CCK) on age as shown by regression analysis. Empty symbols depict
individual values of CCK-induced change in Tc of rats belonging to different age-groups
(n = 43). One symbol may represent several identical values.
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by enhancing the transport of (anorexic) leptin through the blood–
brain-barrier (Cano et al., 2008), or possibly it acts directly at other
structures of the brain. The anorexic effect of IP CCK in young adults
appears to be related to the actual feeding state rather than the more
chronic nutritional state, still, in rats the lack of CCK1R-s is connected
with obesity [Otsuka Long Evans Tokushima (OLETF) rats], suggesting
a possible long-term role of CCK1R activity in energy balance. These
rats eat more and become obese, probably due to lack of satiety and
to a high hypothalamic neuropeptide Y tone (Bi et al., 2004). Satiety def-
icit has also been demonstrated for CCK1R knockout mice (Kopin et al.,
1999). In discrete brain areas presence of CCK1R-s has also been demon-
strated (Hirosue et al., 1993) although in the brain CCK2R-s represent the
dominant and abundant receptor type.
Brain CCK2R-s are generally accepted to have a role in anxiety
behavior (Wang et al., 2005), but such receptors in the dorsomedial,
paraventricular and ventromedial hypothalamic nuclei might also
be mediators of anorexia. Following food intake CCK is released
in the hypothalamus (Schick et al., 1990), probably due to signals
from the stretch of the stomach which signals are conveyed by afferent
vagal activity. Exogenous CCK given ICV or to various hypothalamic nu-
clei suppressed food intake in a number of species (Blevins et al., 2000).
A similar role for endogenous CCK was demonstrated by postponing
satiety via CCK2R antagonist treatment (Dourish et al., 1989). Other
studies demonstrated that CCK2R knockout mice are hyperphagic and
obese (Clerc et al., 2007) — their hypothalamic NPY expression was
also high (Chen et al., 2006). Centrally applied CCK also induced fever-
like elevation of body temperature (Szelényi et al., 1994), and capsaicin
desensitization of the abdominal vagus, i.e., elimination of CCK-sensing
ﬁbers (Pétervári et al., 2005) or pretreatment with CCK1R antagonist
devazepide (Pétervári et al., 2004) prevented the gastric stretch-
induced postprandial hypermetabolism and hyperthermia.
We hypothesized that after the young adult age either the peripheral
or the central CCK effects may vary with further aging. Age-dependence
has already beendemonstrated for the effects of a number of peptides in-
volved in the regulation of food intake, energy balance, thermoregulation
and bodyweight. For example, ICV alpha-MSHhas a very strong anorexic
and body weight decreasing action in young adult and again in old
animals, but not in the middle-aged ones (Pétervári et al., 2010). Such
alterations in activity may contribute to the explanation of the two
basic age-related anomalies of energy balance, i.e., the age-related obesi-
ty and the late-appearing anorexia of aging that often leads to senile
cachexia and sarcopenia — both anomalies having far-reaching health
effects. In contrast, for some other peptides, e.g., neuropeptide Y, ghrelin,
orexin (Akimoto and Miyasaka, 2010) and leptin (Scarpace and Tümer,
2001) another pattern of age-related change, a continuous attenuation
of the effects has been demonstrated suggesting a stepwise deterioration
with age for the regulatory role of the peptide.We assumed that similarly
as the role(s) of other peptides, age-related variations of the CCK-
dependent regulatory effects possibly contribute to the alterations of
energy balance during aging. However, the age-related changes in CCK-
efﬁcacy may show either of these patterns. The present data suggest
that, depending on the point of action, both patterns are possible for CCK.
Although IP injected CCK suppressed the ingestive behavior in young
adult (NF4, NF6) rats, by the age of 12 months this effect of CCK was
practically lost. Later on, however, in old animals (NF18, NF24) the an-
orexic responsiveness to IP administered CCK increased again. The appli-
cation of one single intraperitoneal dose of CCK (5 μg) in our study
(instead of varying the dose in proportion to bodyweight of the animals)
may constitute certain limitations of interpretation of our data. However,
when regarding the CCK dose normalized to 100 g body weight, it ap-
pears that the highest relative dose in juvenile animals remained inefﬁ-
cient, while the lowest relative doses in old age-groups or middle-aged
diet-induced obese rats reduced food intake signiﬁcantly. In addition,
within the young adult group the dose of 1 μg (unpublished data of
Balasko et al.) was also able to induce similar and signiﬁcant suppressionof food intake in a similar setting as the 5 μg dose. Moreover, body
weights of all NF adult age-groups were rather similar to one another,
while showing signiﬁcantly different responses to an identical dose
of CCK. These latter ﬁndings also support our conclusion that CCK-
resistance in our middle-aged groups is based on lack of responsiveness
and not on an insufﬁcient dose.
Enhanced responsiveness to CCK in the old age-group may be
surprising in view of age-related leptin resistance as there is a well-
documented interdependence between effects of these catabolic pep-
tides of mainly peripheral origin (de Lartigue et al., 2012). Although
leptin signaling in vagal afferent neurons is required for appropriate
satiating effects of CCK, moreover high-fat diet-induced leptin resis-
tance reduced this satiating effect (at low doses) in young adult rats
(de Lartigue et al., 2012), it has not been completely abolished. A higher
dose of CCK was shown to inhibit food intake (de Lartigue et al., 2012).
As CCK level increases in old age-groups (as discussed later) where
some leptin resistance but not complete abolishment of leptin effects
is seen, this higher CCK level may be sufﬁcient to induce anorexia.
Melanocortin agonist alpha-MSH (Pétervári et al., 2010) that acts down-
stream of leptin in the hypothalamus shows similar enhancement of
anorexigenic efﬁcacy in old age-groups despite leptin-resistance.
The above demonstrated changes in the efﬁcacy to CCK during the
course of aging may contribute to insufﬁcient satiety, overeating and
obesity inmiddle-aged rats (age-related obesity) aswell as to enhanced
satiety and aging anorexia in old animals. As a ﬁrst approach, the
satiety-inducing effect of CCK seems to suggest that it inﬂuences the
short-term rather than the long-term regulation of food intake. Still,
it has been repeatedly reported (Smith et al., 1985) that not so much
the number, rather the duration of feeding bouts (determining meal
size) is decreased by the peptide what is apparently not fully com-
pensated by feeding frequency. This allows for long-term shifts in energy
balance as cumulative effects of changing CCK activity or efﬁcacy. This is
likely to be the explanation of obesity in OLETF rats.
It may be of particular importance that – according to most human
data – the fasting plasma levels of CCK are higher in the elderly than
in young individuals (Di Francesco et al., 2005; MacIntosh et al., 2001;
Serra-Prat et al., 2009). This results in a suppressed level of hunger
that is not altered very much by the relatively small postprandial CCK-
release in old persons (Serra-Prat et al., 2009). A period of caloric restric-
tion is poorly compensated in elderly men (Winkels et al., 2011).
Animal experiments similarly show higher CCK levels in old animals:
in synaptosomes of brain samples from old rats the CCK-content was
higher than in young ones, although the CCK-release in the brain samples
upon stimulation was smaller (Ohta et al., 1995).
There are limited and controversial data concerningCCKproduction/
effect (and effects of other neuropeptides) in the high-fat diet-induced
obese rat models even in the young adult age-group. Such dietary inter-
ventions were shown to lead to elevation of plasma CCK-concentration
in rats (Li et al., 2011). Nevertheless, various effects of exogenous CCK
are not necessarily simultaneously enhanced (How et al., 2011; Little
et al., 2008). Other reports described suppression of gastrointestinal
CCK gene- and protein expression (as well as those of peptide YY and
glucagon-like peptide-1) (Duca et al., 2013) and reduced satiety in
response to CCK and bombesine (Covasa and Ritter, 1998; Torregrossa
and Smith, 2003). No relevant information regarding age-related alter-
ations in CCK level or activity are available in high-fat diet-induced
obese rodent models.
The effects of long-term calorie-restriction have not been investigated
on peripheral CCK expression or activity either in young adult rats or
during the course of aging. According to our previous observations
calorie-restriction appears to enhance some aspects of neuropep-
tide effects (Soos et al., 2010, 2011).
In the present studies CCK-responses were decreased in dietary
obese rats already at the age of 6 months (HF6), unlike the pronounced
anorexic CCK effects in normally fed rats of the same age (NF6). Contrary
to this, in CR rats of probably low plasma CCK levels CCK-resistance did
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fed middle-aged (NF12) rats were “resistant” to CCK-anorexia. In NF
rats a rebound of CCK-responsiveness was observed with aging after
middle-age (i.e., in NF18–NF24 groups), in HF rats the rebound was
present already at the age of 12 months. Apparently, calorie-restriction
seemed to postpone, obesity to speed up the age-related changes in
CCK-responsiveness.
It may be concluded that peripheral CCK-actions seem to be impor-
tant in the overall energy balance by determining food intake and conse-
quently the nutritional state. These actions change with phases of aging
and they also depend on body composition.
The ICV injected CCK suppressed the ingestive behavior in young
adult rats, but – unlike in the case of IP administration – this effect of
the peptide became gradually weaker with the aging process and by
the age of 24 months (NF24) therewas practically no effect. Apparently,
not only the anorexic, but also the hypermetabolic and hyperthermic
effects of ICV CCK vanished with increasing age. This pattern of change
in neuropeptide effects is characteristic for some peptides like NPY,
ghrelin, orexin, etc. (Akimoto and Miyasaka, 2010). Considering that a
decrease in metabolic rate is characteristic for old age (McGandy et al.,
1966), the lack of effect of centrally applied CCK suggests that the central
CCK activity may have but little importance in determining metabolic
rate, at least in old animals, while the lack of anorexic effect in old rats
suggests that the age-related anorexia is probably also independent of
central CCK activity.
Altogether, cerebral CCK2R-s are likely to have some catabolic
role in energy balance of young adult animals: the CCK2R-dependent
postprandial anorexia and hypermetabolism possibly play a role in the
metabolic adaptation to calorie intake, to maintain energy equilibrium.
Studies on the control of food intake in older men have shown that,
unlike in their young counterparts, an excessive calorie containing diet
of the same length was not readily compensated following the dietary
period — this is part of the phenomenon known as “dysorexia” of the
elderly (Roberts et al., 1994).
Central CCK (CCK2R-s) may also participate in fever and sickness
behavior (Székely et al., 1994; Weiland et al., 2007). Aging is associated
with diminished fever response (Buchanan et al., 2003).
Central CCK-actions seem to be important in the overall energy
balance by determining fever-like metabolic response with additional
anorexic effect. According to our data these effects decline with aging.
Our present ﬁndings raise the hypothesis that age-related decline
in the central hyperthermic and anorexic effects of CCK may contribute
to the age-related diminishment of fever, alterations in sickness behavior
and insufﬁciency of metabolic adaptation to feeding.
Although CCK of peripheral origin also acts in the brain, on its
CCK1R-s at various nuclei, the points of action of this CCK and those
of centrally applied/released CCK (acting on CCK2R-s of the brain)
cannot be identical as shown by the opposite metabolic/thermal
effects and by the fact that the age-related changes in their efﬁcacy
are different.5. Concluding remarks and perspectives
5.1. Conclusions
Both the peripheral and the central CCK-effects (anorexic as well as
metabolic effects) are age-dependent. The peripheral effects change
with age andmay contribute to the age-related phasic changes in overall
energy balance and consequent changes in body weight, i.e., to the age-
related obesity in middle-aged and the aging anorexia in old subjects.
The central effectsmay change in away that themetabolic compensation
of calorie intake (postprandial hypermetabolism) becomes atte-
nuated or is lost completely in old age. Diet-induced obesity appears
to accelerate, calorie-restriction to slow down these age-related
processes.5.2. Perspectives
Our results raise the hypothesis that peripheral and central receptor
mechanisms of CCK play distinctly differential roles in the regulation
of energy balance. Short-term regulation of food intake and the charac-
teristic shifts in the long-term regulation of energy balance in the course
of life (depending on the nutritional state) appear to be connected
mainly with peripheral receptors, while the activity of central receptors
may present a metabolic compensation for calorie intake and defense
against energy accumulation in young age-groups. In old rats the loss
of metabolic responsiveness to centrally applied CCK appears to be rea-
sonable, since these animals tend to lose weight anyhow, and a high
metabolic response to calorie intake would speed up this unfavorable
process (this is exactly what may be connected with the increased
sensitivity to peripheral CCK). It may be of interest to see whether
the loss of metabolic responsiveness is similar in obese old rats
with abundant energy reserves some of which may be lost without
severe consequences. Speciﬁc antagonists of peripheral and central
CCK receptors would be useful in the analysis of differential CCK
functions during the course of aging.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.exger.2013.07.006.
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